Annual report pursuant to Section 13 and 15(d)

Schedule of Basic and Diluted Loss Per Share (Details)

v3.23.1
Schedule of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Net loss $ (12,039) $ (9,309)
Net loss, effect of dilutive warrant securities (2,807) (696)
Net loss, diluted calculation (14,846) (10,005)
Deemed dividend and accretion of a discount, basic calculation (4,450)
Deemed dividend and accretion of a discount, effect of dilutive warrant securities
Deemed dividend and accretion of a discount, diluted calculation (4,450)
Net loss attributable to common stockholders, basic calculation (16,489) (9,309)
Net loss attributable to common stockholders, effect of dilutive warrant securities (2,807) (696)
Net loss attributable to common stockholders, diluted calculation $ (19,296) $ (10,005)
Number of shares used in per common share calculations: basic calculation 301,610 246,919
Number of shares used in per common share calculations: effect of dilutive warrant securities 15,713 3,782
Number of shares used in per common share calculations: diluted calculation 317,323 250,701
Net loss, basic calculation $ (39.92) $ (37.70)
Net loss, effect of dilutive warrant securities (6.87) (2.21)
Net loss, diluted calculation (46.79) (39.91)
Deemed dividend and accretion of a discount, basic calculation (14.75)
Deemed dividend and accretion of a discount, effect of dilutive warrant securities 0.73
Deemed dividend and accretion of a discount, diluted calculation (14.02)
Net loss attributable to common stockholders, basic calculation (54.67) (37.70)
Net loss attributable to common stockholders, effect of dilutive warrant securities (6.14) (2.21)
Net loss attributable to common stockholders, diluted calculation $ (60.81) $ (39.91)